Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Postgrad Med J ; 98(1164): 799-810, 2022 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-37062993

RESUMO

Children with genodermatoses are at an increased risk of developing behavioural disorders which may impart lasting damage on the individual and their family members. As such, early recognition of childhood mental health disorders via meticulous history taking, thorough physical examination, and disorder-specific testing is of paramount importance for timely and effective intervention. If carried out properly, prompt psychiatric screening and intervention can effectively mitigate, prevent or even reverse, the psychiatric sequela in question. To that end, this review aims to inform the concerned physician of the manifestations and treatment strategies relevant to the psychological sequelae of genodermatoses.


Assuntos
Transtornos Mentais , Dermatopatias Genéticas , Criança , Humanos , Transtornos Mentais/diagnóstico , Transtornos Mentais/etiologia , Transtornos Mentais/psicologia , Dermatopatias Genéticas/complicações
2.
Clin Exp Pharmacol Physiol ; 48(9): 1298-1299, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-33768564

RESUMO

Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of a variety of oncological conditions. It has been associated with a spectrum of pigmentary cutaneous side effects. Despite the well-known association of eruptive melanocytic nevi with the use of other tyrosine kinase inhibitors, this phenomenon has not been linked to the administration of imatinib. We present the first case of imatinib-induced eruptive nevi in an 18-year-old patient with acute lymphocytic leukaemia in remission.


Assuntos
Mesilato de Imatinib
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA